Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficac
BostonGene Announces Acceptance of Eight Abstracts to be Presented at the A
GE HealthCare closes MIM Software acquisition, bolstering its portfolio and
GPCR Therapeutics Announces Publication in PNAS Using Cutting Edge Spectros
BostonGene Recognized as Designated Laboratory for the ComboMATCH Precision
Springer Nature and the Breast Cancer Research Foundation Announce the Risi
A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of
Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowd
Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration
ImpriMed to Present Innovative Research at 2024 World Veterinary Cancer Con
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisert
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider